By Keith L. Carson
Volume 14, Issue 2 (Summer 2015)
As an industry, we need to do far more to implement technologies and work with FDA, not only to keep them informed, but to make sure they are aware of industry trends and newer technologies. Remember that CBER and CDER have their own labs, and in many cases, they will want to bring in the technologies you want to use and see how they work in their own experiments…
Citation: Carson KL. From the Editor-in-Chief: Applying More Automation to Our BioProcessing. BioProcess J, 2015; 14(2): 3. https://doi.org/10.12665/J142.Carson
Posted online July 28, 2026